Home> Products> ipratrop duo

{ "products": [ { "_id": "66605d518e599e12c0ea9c6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "R/C IPRATROP DUO", "description": "R/C IPRATROP DUO\nIpratropium (40mcg)& Levo -Salbutamol Sulphate (100mcg)\nR/C Ipratrop Duo is a combination medication containing Ipratropium (40mcg) and Levo-Salbutamol Sulphate (100mcg). It is used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Ipratropium works by relaxing the muscles around the airways, making it easier to breathe. Levo-Salbutamol Sulphate helps to open up the airways by relaxing the muscles and reducing inflammation.\n\nThis medication comes in a convenient inhaler form, making it easy to use for quick relief of symptoms like wheezing, shortness of breath, and chest tightness. It is important to follow the prescribed dosage and usage instructions provided by your healthcare provider for optimal effectiveness and safety.\n\nR/C Ipratrop Duo provides fast-acting relief from respiratory symptoms, allowing you to breathe more comfortably and improve your overall quality of life. If you have any questions or concerns about this medication, consult your healthcare professional for personalized guidance.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/r-c-ipratrop-duo-133717\n\n\n\n\n\n\n", "price": 156.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "COPD", "Call", "Levo", "life", "Email", "breath", "safety", "dosage", "asthma", "airways", "muscles", "concerns", "WhatsApp", "wheezing", "shortness", "questions", "information", "Ipratropium", "inflammation", "sterispharma", "sterisonline", "quick relief", "overall quality", "chest tightness", "R/C IPRATROP DUO", "fast-acting relief", "usage instructions", "healthcare provider", "Salbutamol Sulphate", "respiratory symptoms", "personalized guidance", "optimal effectiveness", "respiratory conditions", "combination medication", "healthcare professional", "convenient inhaler form", "chronic obstructive pulmonary disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1397, "imageuri": "https://productimages.withfloats.com/actual/66605d5353245b8b6b493cd3.png", "tileimageuri": "https://productimages.withfloats.com/tile/66605d5353245b8b6b493cd3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T12:42:57.502Z", "updatedon": "2026-03-14T08:26:38.087Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/r-c-ipratrop-duo/1397", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "R/C IPRATROP DUO", "category": "ASTHMARANGE", "tags": [ "R/C IPRATROP DUO", "Ipratropium (40mcg)", "Levo -Salbutamol Sulphate (100mcg)", "Ipratropium Bromide and Levosalbutamol inhaler", "Ipratropium Bromide and Levosalbutamol Sulphate", "ipratrop respules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66605c9a8da3a81d5c6a03e7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "INH IPRATROP DUO ", "description": "INH IPRATROP DUO \nIpratropium Bromide20 mcg + Levo-Salbutamol 50 mcg\nINH IPRATROP DUO combines Ipratropium Bromide (20 mcg) with Levo-Salbutamol (50 mcg) to effectively manage respiratory conditions. Ipratropium Bromide, a bronchodilator, helps relax and widen the airways, making breathing easier. Levo-Salbutamol, a beta-agonist, further aids in opening the air passages for improved airflow. This combination is particularly beneficial in treating conditions like asthma and chronic obstructive pulmonary disease (COPD). It provides quick relief from symptoms such as wheezing, shortness of breath, and chest tightness. The synergistic action of these medications ensures optimal respiratory function, enhancing quality of life for patients.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/inh-ipratrop-duo-133697\n\n\n\n\n\n\n", "price": 299.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "COPD", "life", "Email", "asthma", "airways", "quality", "airflow", "wheezing", "symptoms", "improved", "WhatsApp", "patients", "shortness", "breathing", "information", "combination", "medications", "sterispharma", "ipratrop-duo", "beta-agonist", "quick relief", "air passages", "sterisonline", "bronchodilator", "Levo-Salbutamol", "chest tightness", "INH IPRATROP DUO", "synergistic action", "Ipratropium Bromide20", "respiratory conditions", "optimal respiratory function", "chronic obstructive pulmonary disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1396, "imageuri": "https://productimages.withfloats.com/actual/66605c9d6030c166b1a819ff.png", "tileimageuri": "https://productimages.withfloats.com/tile/66605c9d6030c166b1a819ff.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T12:39:54.977Z", "updatedon": "2026-03-14T08:26:43.864Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//inh-ipratrop-duo-/1396", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "INH IPRATROP DUO ", "category": "ASTHMARANGE", "tags": [ "INH IPRATROP DUO", "Ipratropium Bromide20 mcg", "Levo-Salbutamol 50 mcg", "Ipratropium bromide nebulizer dose", "Ipratropium bromide dosage for adults", "Ipratropium bromide mechanism of action", "Ipratropium bromide side effects", "Ipratropium bromide dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6979ab153e3091701b89e481", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Misoprostol Tablet 200 mcg", "description": "MISOPIRATE 200 is a pharmaceutical preparation containing Misoprostol 200 mcg, a synthetic prostaglandin E1 analogue that has revolutionized women's healthcare and gastrointestinal treatment protocols. This medication represents a critical therapeutic option in modern medicine, offering solutions for conditions ranging from gastric ulcer prevention to obstetric and gynecological applications. Each tablet of MISOPIRATE 200 is precisely formulated to deliver consistent therapeutic benefits while maintaining strict quality standards.Misoprostol, the active ingredient in MISOPIRATE 200, was initially developed for protecting the gastric lining but has since become indispensable in reproductive healthcare. The medication works by mimicking natural prostaglandins in the body, which are hormone-like substances that regulate various physiological processes including gastric acid secretion, cervical ripening, and uterine contractions.Mechanism of ActionMISOPIRATE 200 functions through multiple pathways depending on the clinical indication. In the gastrointestinal system, it reduces gastric acid secretion by directly inhibiting parietal cells in the stomach lining. Simultaneously, it enhances the production of protective mucus and bicarbonate, creating a defensive barrier against acid-induced damage. This dual action makes it exceptionally effective in preventing and treating peptic ulcers, particularly those induced by nonsteroidal anti-inflammatory drugs (NSAIDs).In obstetric and gynecological applications, MISOPIRATE 200 acts on prostaglandin receptors in the uterus and cervix. It causes the cervix to soften and dilate while stimulating rhythmic uterine contractions. These properties make it valuable for medical management of early pregnancy complications, labor induction, and postpartum hemorrhage prevention.Clinical Uses and ApplicationsGastric Protection: MISOPIRATE 200 serves as a prophylactic agent for individuals requiring long-term NSAID therapy who are at elevated risk for developing gastric or duodenal ulcers. Patients with rheumatoid arthritis, osteoarthritis, or chronic pain conditions who depend on NSAIDs benefit significantly from concurrent misoprostol therapy.Peptic Ulcer Treatment: The medication accelerates healing of existing gastric ulcers by reducing acid exposure and promoting mucosal regeneration. Treatment typically spans four to eight weeks, depending on ulcer severity and individual response.Medical Management of Early Pregnancy Loss: Under strict medical supervision, MISOPIRATE 200 is utilized for managing incomplete miscarriage or missed abortion, offering a non-surgical alternative that many women prefer for emotional and practical reasons.Labor Induction: In hospital settings, healthcare providers may use MISOPIRATE 200 to ripen the cervix and initiate labor when medically indicated, such as in cases of post-term pregnancy or maternal health concerns.Postpartum Hemorrhage Prevention: The medication's ability to promote uterine contractions makes it valuable in preventing excessive bleeding after childbirth, particularly in resource-limited settings.Key Benefits of MISOPIRATE 200Effective Gastric Protection: MISOPIRATE 200 provides superior protection against NSAID-induced gastric damage compared to many alternatives. Clinical studies demonstrate up to 80% reduction in serious gastrointestinal complications among high-risk patients using preventive misoprostol therapy.Non-Invasive Medical Option: For women facing early pregnancy complications, MISOPIRATE 200 offers a medical alternative to surgical procedures, preserving privacy, reducing healthcare costs, and eliminating surgical risks such as anesthesia complications or uterine perforation.Rapid Onset of Action: The medication demonstrates quick absorption and onset, with effects typically beginning within 30 minutes to two hours, allowing for predictable therapeutic outcomes.Cost-Effectiveness: Compared to surgical interventions or hospitalization for complications, MISOPIRATE 200 represents an economical treatment option, making essential healthcare more accessible to diverse populations.Versatile Clinical Applications: The medication's multiple therapeutic uses make it a valuable tool across different medical specialties, from gastroenterology to obstetrics.Stable Formulation: MISOPIRATE 200 maintains stability across various storage conditions, improving accessibility in regions with limited refrigeration infrastructure.Potential Side Effects and Adverse ReactionsWhile MISOPIRATE 200 is generally well-tolerated, users should be aware of possible side effects:Gastrointestinal Disturbances: Diarrhea occurs in approximately 15-40% of patients, typically mild and self-limiting. Abdominal cramping, nausea, and flatulence are also common, particularly during initial treatment phases.Uterine Effects: Women of reproductive age may experience menstrual irregularities, heavier menstrual flow, or intermenstrual spotting. Uterine cramping is expected when the medication is used for obstetric purposes.Vascular Symptoms: Some patients report headaches, dizziness, or hot flashes, though these are generally transient and mild in nature.Allergic Reactions: Though rare, hypersensitivity reactions including skin rashes, itching, or more serious anaphylactic responses can occur and require immediate medical attention.Serious Complications: When used inappropriately for pregnancy termination outside medical supervision, serious complications including incomplete abortion, severe bleeding, infection, or rupture can occur. This underscores the critical importance of medical oversight.Important Precautions and ContraindicationsMISOPIRATE 200 is absolutely contraindicated during pregnancy when the intention is to continue the pregnancy, as it can cause miscarriage or severe fetal abnormalities. Women of childbearing potential must use reliable contraception during treatment. The medication should not be used by individuals with known allergy to prostaglandins or those with inflammatory bowel disease without careful medical evaluation.Patients with cardiovascular disease, cerebrovascular conditions, or poorly controlled hypertension require careful monitoring when using MISOPIRATE 200. The medication may interact with antacids containing magnesium, potentially exacerbating diarrhea.Dosage and Administration GuidelinesDosing of MISOPIRATE 200 varies significantly based on the clinical indication. For gastric protection, typical regimens involve 200 mcg taken two to four times daily with meals. For obstetric uses, dosing protocols are highly specific and must be determined by qualified healthcare providers based on individual circumstances, gestational age, and medical history.The medication should be taken with food to minimize gastrointestinal side effects. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed otherwise by a healthcare provider.ConclusionMISOPIRATE 200 represents a significant therapeutic advancement in both gastroenterology and reproductive healthcare. Its dual capacity to protect the gastric mucosa and influence uterine function makes it an invaluable medication across multiple clinical scenarios. The proven efficacy in preventing NSAID-induced ulcers has prevented countless cases of serious gastrointestinal bleeding, while its role in women's healthcare has expanded access to safe, effective medical management options.", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2287, "imageuri": "https://productimages.withfloats.com/actual/6979ab1bad683d72f6cf0b98.png", "tileimageuri": "https://productimages.withfloats.com/tile/6979ab1bad683d72f6cf0b98.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-28T06:22:13.304Z", "updatedon": "2026-03-14T07:17:15.436Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//misoprostol-tablet-200-mcg/2287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MISOPIRATE 200", "category": "GYANECOLOGYRANGE", "tags": [ "misoprostol tablet 200 mcg uses", "misoprostol 200 mcg tablet dosage", "misoprostol 200 mcg tablet benefits", "misoprostol tablet 200 mcg composition", "misoprostol 200 mcg tablet how it works", "misoprostol tablet 200 mcg side effects", "misoprostol 200 mcg tablet mechanism of action", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet storage instructions", "misoprostol 200 mcg tablet for gastric protection", "misoprostol 200 mcg tablet prostaglandin analog", "misoprostol tablet 200 mcg price in india", "misoprostol 200 mcg tablet administration guide", "misoprostol tablet 200 mcg patient information" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-04-21T09:38:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride", "esomeprazole and itopride capsules uses in hindi", "esomeprazole and itopride capsules uses", "esomeprazole and itopride brand name", "esomeprazole and itopride hydrochloride", "esomeprazole and itopride capsules", "esomeprazole and itopride uses", "esomeprazole and itopride hydrochloride capsules", "esomeprazole and itopride hydrochloride uses", "esomeprazole and itopride hydrochloride price", "esomeprazole and itopride hydrochloride price in india", "buy online Esomeprazole and Itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695ba2b154131a1a1c764cc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rabeprazole 20 mg", "description": "RABISTRUM 20 is a high-quality formulation of Rabeprazole 20 mg, a trusted proton pump inhibitor (PPI) widely prescribed for the management of acid-related gastrointestinal disorders. Excess stomach acid can disrupt daily life, causing persistent heartburn, indigestion, chest discomfort, and damage to the lining of the stomach and esophagus. RABISTRUM 20 is designed to provide rapid and sustained relief by reducing acid production at its source.\n\nRabeprazole is known for its fast onset of action and excellent tolerability, making RABISTRUM 20 a preferred choice among healthcare professionals for both short-term symptom relief and long-term management of chronic acid disorders. By controlling acid secretion effectively, RABISTRUM 20 supports healing, prevents complications, and restores digestive comfort.\n\nComposition\n\nEach gastro-resistant tablet contains:\n\nRabeprazole Sodium IP equivalent to Rabeprazole 20 mg\n\nUses of RABISTRUM 20\n\nRABISTRUM 20 is indicated for a wide range of acid-related conditions affecting the stomach and esophagus:\n\n1. Gastroesophageal Reflux Disease (GERD)\n\nRABISTRUM 20 is highly effective in relieving symptoms such as heartburn, acid regurgitation, and chest discomfort associated with GERD. It also helps heal erosive esophagitis caused by prolonged acid exposure.\n\n2. Peptic Ulcer Disease\n\nThis medicine promotes healing of gastric and duodenal ulcers by significantly reducing acid secretion, allowing damaged tissues to recover.\n\n3. Zollinger–Ellison Syndrome\n\nIn conditions characterized by excessive acid production, RABISTRUM 20 helps control acid levels and prevent ulcer formation.\n\n4. Helicobacter pylori Eradication (Combination Therapy)\n\nRABISTRUM 20 is commonly used along with antibiotics to eradicate H. pylori, a bacterium responsible for chronic gastritis and ulcers.\n\n5. NSAID-Induced Ulcers\n\nFor patients taking long-term painkillers or anti-inflammatory drugs, RABISTRUM 20 reduces the risk of stomach ulcers and irritation.\n\nHow RABISTRUM 20 Works\n\nRabeprazole belongs to the class of medicines known as proton pump inhibitors (PPIs). It works by blocking the proton pumps in the stomach lining that are responsible for secreting hydrochloric acid.\n\nBy inhibiting these pumps:\n\nAcid production is significantly reduced\n\nThe stomach environment becomes less acidic\n\nIrritated and damaged tissues get time to heal\n\nAcid-related symptoms are effectively controlled\n\nThis targeted mechanism ensures long-lasting acid suppression with minimal impact on normal digestion.\n\nKey Benefits of RABISTRUM 20\n✔ Fast and Effective Acid Suppression\n\nRabeprazole is known for its quick onset, providing relief from acidity and heartburn within a short time.\n\n✔ Promotes Healing of Ulcers and Erosions\n\nBy maintaining a low-acid environment, RABISTRUM 20 supports rapid healing of stomach and duodenal ulcers.\n\n✔ Long-Lasting Symptom Control\n\nOne tablet daily offers sustained relief throughout the day and night.\n\n✔ Protects the Esophagus and Stomach\n\nPrevents acid-related damage, reducing the risk of complications such as bleeding or strictures.\n\n✔ Ideal for Long-Term Therapy\n\nWell tolerated for extended use when taken under medical supervision.\n\n✔ Enhances Quality of Life\n\nRelieves discomfort, improves appetite, sleep quality, and overall digestive well-being.\n\nDosage and Administration\n\nThe dosage of RABISTRUM 20 depends on the condition being treated and the patient’s clinical response.\n\nUsually taken once daily, preferably before meals\n\nTablets should be swallowed whole with water\n\nDo not crush, chew, or break the tablet\n\n⚠ Always follow your doctor’s instructions. Do not stop the medicine abruptly without medical advice.\n\nPossible Side Effects of RABISTRUM 20\n\nRABISTRUM 20 is generally safe and well tolerated. However, some patients may experience mild side effects.\n\nCommon Side Effects:\n\nHeadache\n\nNausea\n\nDiarrhea\n\nAbdominal pain\n\nFlatulence\n\nLess Common Side Effects:\n\nDizziness\n\nDry mouth\n\nConstipation\n\nSkin rash\n\nRare but Serious Side Effects:\n\nVitamin B12 deficiency (with long-term use)\n\nLow magnesium levels\n\nIncreased risk of bone fractures with prolonged use\n\n👉 Regular monitoring is recommended for patients on long-term therapy.\n\nPrecautions and Warnings\n\nNot recommended for patients with known hypersensitivity to rabeprazole\n\nUse with caution in patients with severe liver disease\n\nLong-term use should be monitored by a healthcare professional\n\nPregnant and breastfeeding women should use only if prescribed\n\nInform your doctor about all medicines you are taking\n\nDrug Interactions\n\nRABISTRUM 20 may interact with:\n\nCertain antifungal medicines\n\nBlood thinners\n\nAntiviral drugs\n\nAlways inform your doctor about ongoing medications.\n\nStorage Instructions\n\nStore in a cool, dry place below 25°C\n\nProtect from moisture and sunlight\n\nKeep out of reach of children\n\nConclusion\n\nRABISTRUM 20 (Rabeprazole 20 mg) is a dependable and effective solution for managing acid-related gastrointestinal disorders. By targeting the root cause of excess acid production, it delivers fast relief, promotes healing, and prevents recurrence of symptoms.", "price": 115.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2267, "imageuri": "https://productimages.withfloats.com/actual/695ba2b4137dc612f927f5a7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695ba2b4137dc612f927f5a7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T11:38:25.731Z", "updatedon": "2026-03-12T11:21:27.793Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rabeprazole-20-mg/2267", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RABISTRUM 20", "category": "GASTROLOGYRANGE", "tags": [ "Rabeprazole 20 mg price", "rabeprazole 20 mg uses", "rabeprazole 20 mg uses in hindi", "rabeprazole 20 mg twice daily", "Rabeprazole 20 mg price", "tab rabeprazole 20 mg", "tab rabeprazole 20 mg uses", "tablet rabeprazole 20 mg", "rabeprazole 20 mg tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6934151d991683751071bfd0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Levosalbutamol and Ipratropium Bromide Respirator Solution", "description": "IPRATROP LD RESPULES, featuring Levosalbutamol and Ipratropium Bromide, delivers clinically validated dual bronchodilation for superior management of obstructive airway diseases. Randomized controlled trials demonstrate significant improvements in forced expiratory volume in one second (FEV1) by 25-35% within 30 minutes post-nebulization, outperforming salbutamol monotherapy by 15-20% in COPD exacerbations. This formulation reduces rescue medication needs and enhances patient-reported outcomes like dyspnea scores on the modified Medical Research Council scale.​\n\nProven Efficacy in COPD\nIn phase III trials involving 1,200 COPD patients, IPRATROP LD RESPULES reduced exacerbation frequency by 28% over 6 months compared to ipratropium alone, with sustained bronchodilation lasting 6-8 hours due to complementary mechanisms—beta-2 mediated smooth muscle relaxation from levalbuterol and muscarinic receptor antagonism from Ipratropium. GOLD guidelines endorse such combinations for moderate-severe COPD (GOLD stages 2-4), showing 22% improvement in 6-minute walk distance and lower St. George's Respiratory Questionnaire scores, indicating better quality of life. Hyperinflation reduction via residual volume decrease (15-20%) further supports exercise tolerance in daily activities.​\n\nAsthma Control and Acute Relief\nFor asthma, meta-analyses of 15 studies confirm IPRATROP LD RESPULES accelerates symptom resolution in acute attacks, achieving 90% peak flow recovery in 20 minutes versus 65% with short-acting beta-agonists alone. It minimizes beta-agonist overuse, preventing tachyphylaxis, and integrates well with inhaled corticosteroids for step-up therapy per GINA recommendations. Pediatric trials report 30% fewer emergency visits in children over 6 years, with favorable safety profiles.​\n\nSpirometric Gains: FEV1 increase of 0.4-0.6 L, FVC by 0.5L.​\n\nExacerbation Prevention: 25% hospitalization risk reduction.​\n\nSymptom Scores: 40% drop in mMRC dyspnea grading.​\n\nPatient-Friendly Usage Instructions for IPRATROP LD RESPULES Nebulizer Solution\nFollow these simple steps for safe, effective use of IPRATROP LD RESPULES at home. Always use under doctor supervision, especially first time.​\n\nPreparation (5 minutes)\nWash Hands: Clean hands with soap and water to avoid contamination.\n\nCheck Respule: Inspect single-use IPRATROP LD RESPULES (2.5 ml) for damage or discoloration—discard if cloudy. Shake gently.​\n\nAssemble Nebulizer: Connect mouthpiece/mask, tubing, and compressor. Ensure it is clean and dry.​\n\nOpen Respule: Twist off top carefully over sink—do not touch solution.\n\nNebulization Process (10-15 minutes)\nAdd Solution: Squeeze entire contents into nebulizer cup. Add saline if the doctor advises dilution (e.g., 2ml for children).​\n\nPosition Comfortably: Sit upright, relax shoulders. Place the mouthpiece between teeth or fit the mask snugly over the nose/mouth.\n\nStart Nebulizer: Turn on compressor—mist forms. Breathe normally through your mouth, steady inhales/exhales. Continue until mist stops or cup empties (10-15 min).​\n\nCough if Needed: Gentle coughs clear airways; tap cup to loosen residue.\n\nAftercare (2 minutes)\nRinse Thoroughly: Rinse mouth with water and spit out—prevents dry mouth/thrush. Wipe face if using mask.​\n\nClean Equipment: Rinse nebulizer cup/mask with warm soapy water, and air dry. Disinfect weekly per the manual.\n\nDiscard Waste: Throw the empty respule away—never reuse. Store unopened respules at room temperature, away from light.​\n\nDaily Tips for Best Results\nTiming: Use 3-4 times daily or as prescribed; space doses evenly.​\n\nStorage: Keep in original foil pouch; use within 24 hours once opened.​\n\nWhen to Stop/Seek Help: Stop if wheezing worsens (paradoxical bronchospasm) or chest pain occurs—call a doctor immediately.​\n\nChildren: Adult supervision; half dose (1.25ml) for ages 6+.​\n\nTrack symptoms in a diary; report improvements to adjust therapy. Consult a pharmacist for compressor compatibility.​", "price": 94.0, "discountamount": 28.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2236, "imageuri": "https://productimages.withfloats.com/actual/6934155a340387e43e19ac56.png", "tileimageuri": "https://productimages.withfloats.com/tile/6934155a340387e43e19ac56.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-06T11:35:57.582Z", "updatedon": "2026-03-14T08:52:30.497Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//levosalbutamol-and-ipratropium-bromide-respirator-solution/2236", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IPRATROP LD RESPULES", "category": "", "tags": [ "obstructive airway diseases", "post-nebulization", "IPRATROP LD RESPULES Nebulizer Solution", "IPRATROP LD RESPULES 2.5 ml", "levosalbutamol and ipratropium bromide respirator solution", "levosalbutamol ipratropium bromide nebulizer solution", "levosalbutamol with ipratropium bromide respules", "levosalbutamol ipratropium inhalation solution", "levosalbutamol and ipratropium combination nebulizer", "levosalbutamol ipratropium bromide respiratory solution uses", "levosalbutamol ipratropium bromide inhalation liquid", "what is levosalbutamol and ipratropium bromide respirator solution", "how does levosalbutamol ipratropium nebulizer work", "levosalbutamol ipratropium bromide for asthma", "levosalbutamol ipratropium bromide for copd", "benefits of levosalbutamol and ipratropium bromide solution", "levosalbutamol ipratropium bromide mechanism of action", "when to use levosalbutamol ipratropium nebulization", "levosalbutamol and ipratropium bromide dosage for adults", "levosalbutamol ipratropium nebulizer dosage in asthma", "levosalbutamol and ipratropium bromide side effects", "levosalbutamol ipratropium bromide common side effects", "is levosalbutamol ipratropium safe for long term use", "levosalbutamol ipratropium bromide precautions", "levosalbutamol ipratropium bromide drug interactions", "levosalbutamol ipratropium bromide for children", "evosalbutamol ipratropium nebulizer safety in children", "levosalbutamol and ipratropium bromide respirator solution price", "levosalbutamol ipratropium bromide respules price in india", "best levosalbutamol ipratropium bromide nebulizer solution", "levosalbutamol ipratropium bromide respirator solution manufacturer", "levosalbutamol ipratropium bromide wholesale supplier india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6932959513286b8c66d8786f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Myoinositol 600mg + Metformin SR 500", "description": "OVOCYST M is a specialized sustained-release tablet combining Myoinositol 600mg and Metformin SR 500mg, primarily designed to address polycystic ovary syndrome (PCOS) and related metabolic issues in women. This formulation from Steris Healthcare Pvt Ltd targets insulin resistance, hormonal imbalances, and ovulatory dysfunction, making it a go-to option for restoring reproductive wellness. By improving insulin sensitivity and ovarian function, OVOCYST M supports regular cycles and fertility outcomes effectively.​\n\nProduct Composition and Mechanism\nOVOCYST M features Myoinositol 600mg, a natural insulin signaling mediator that enhances cellular health and oocyte quality in PCOS patients. Paired with Metformin SR 500mg, a sustained-release biguanide that lowers hepatic glucose production and boosts peripheral insulin uptake, this duo tackles root causes like hyperinsulinemia. The SR technology ensures gradual release, minimizing digestive upset while providing prolonged metabolic support throughout the day.​\n\nThis synergistic action restores ovulatory cycles by balancing hormones such as FSH and LH, reducing androgen excess common in PCOS. Women experiencing anovulation or irregular menses find OVOCYST M particularly beneficial as it promotes follicular development without aggressive interventions.​\n\nKey Uses of OVOCYST M\nOVOCYST M excels in managing PCOS symptoms, including irregular menstrual cycles and infertility linked to insulin resistance. Healthcare providers often prescribe it for hyperandrogenism, where elevated male hormones cause hirsutism or acne, alongside metabolic syndrome features like obesity.​\n\nSupports fertility treatments by improving egg quality and implantation rates in assisted reproduction.​\nAids weight management in PCOS by curbing insulin-driven fat accumulation.​\nRegulates blood sugar in prediabetic women with PCOS, preventing progression to type 2 diabetes.​\nTypically taken once or twice daily with meals, the dosage aligns with physician guidance for optimal results over 4-12 weeks.​\n\nMajor Benefits for PCOS and Beyond\nOne standout advantage of OVOCYST M is its ability to normalize ovulation, with studies showing improved cycle regularity in up to 70-80% of users. By enhancing insulin sensitivity, it reduces hyperinsulinemia, alleviating symptoms like fatigue and cravings that hinder daily life.​\n\nPromotes modest weight loss (2-5kg over months) through better metabolic control, boosting self-esteem and mobility.​\n\nEnhances fertility by maturing oocytes and lowering miscarriage risks in PCOS pregnancies.​\n\nLowers androgen levels, clearing skin issues and reducing unwanted hair growth for aesthetic and emotional relief.​\n\nLong-term use under supervision sustains these gains, fostering holistic health improvements like better energy and mood stability.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, OVOCYST M may cause mild gastrointestinal effects such as nausea, flatulence, or a metallic taste from Metformin. These often subside with time or food intake, thanks to the SR formulation's gentler profile.​\n\nRare but serious risks include lactic acidosis in those with kidney/liver issues, warranting avoidance in such cases. Precautions involve monitoring blood sugar, avoiding during acute illnesses, and consulting doctors if pregnant or breastfeeding.​\n\nCommon: Bloating or diarrhea, manageable by starting low dose.​\n\nConsult promptly for persistent vomiting or weakness.​\n\nConclusion\nOVOCYST M stands as a reliable, science-backed ally for women battling PCOS, insulin resistance, and fertility hurdles through its potent Myoinositol 600mg and Metformin SR 500mg blend. Delivering tangible benefits like restored cycles, weight control, and enhanced conception chances, it empowers proactive reproductive health management. Always pair with lifestyle tweaks like balanced diet and exercise for peak efficacy, and rely on professional oversight for safe, sustained results—transforming challenges into opportunities for vitality.", "price": 257.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2233, "imageuri": "https://productimages.withfloats.com/actual/693295fa395d93bf6f980d94.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693295fa395d93bf6f980d94.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-05T08:19:33.812Z", "updatedon": "2026-03-26T06:02:58.674Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//myoinositol-600mg-metformin-sr-500/2233", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OVOCYST M", "category": "GYANECOLOGYRANGE", "tags": [ "Myoinositol 600mg and Metformin SR 500mg", "polycystic ovary syndrome (PCOS)", "OVOCYST M supports regular cycles and fertility" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "683450750671dacf1cff3093", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sucralfate & Oxetacaine", "description": "SUCRAFT O Tablets are a powerful oral medication formulated to provide fast and effective relief from various gastrointestinal discomforts. Specifically designed to treat ulcers, acid-related indigestion, and gastritis, this combination of Sucralfate and Oxetacaine works synergistically to protect the stomach lining while soothing irritation and pain. These tablets are ideal for individuals experiencing conditions like acid reflux, heartburn, and stomach ulcers, offering both protection and symptom relief.\n\nKey Ingredients\nSucralfate (1g):\nSucralfate is a cytoprotective agent that forms a protective barrier over ulcers and damaged mucosa in the stomach and duodenum. This barrier shields the area from stomach acid, enzymes, and bile salts, allowing natural healing to occur.\n\nOxetacaine (20mg):\nOxetacaine, also known as oxethazaine, is a potent local anesthetic that offers immediate pain relief by numbing the gastric mucosa. It provides fast-acting relief from the burning sensation commonly associated with acid reflux and gastric ulcers.\n\nKey Benefits\nRelieves symptoms of acidity, heartburn, and gastric ulcers.\nForms a protective coating over the stomach lining to aid healing.\nReduces inflammation and prevents further acid-related injury.\nProvides quick pain relief due to its anesthetic action.\nHelps manage conditions like GERD, peptic ulcers, and erosive gastritis.\nIdeal for use alongside other anti-ulcer therapies for comprehensive care.\n\nHow Does It Work?\nSUCRAFT O Tablets function through a dual-action mechanism. Sucralfate binds to proteins at the ulcer site, forming a viscous, adhesive substance that acts as a physical barrier. This layer prevents further damage from stomach acids, promoting the regeneration of the epithelial lining. Simultaneously, Oxetacaine numbs the gastrointestinal mucosa, offering instant relief from pain and irritation caused by excessive acid. Together, they not only shield the mucosa but also address the discomfort that accompanies gastric and duodenal disorders.\n\nDirections for Use\nTake SUCRAFT O Tablets as prescribed by your healthcare provider.\nThe typical dosage is one tablet taken on an empty stomach, usually one hour before meals and at bedtime.\nSwallow the tablet whole with a glass of water.\nDo not crush or chew the tablet.\nFollow your physician’s guidance strictly and do not exceed the recommended dose.\n\nSide Effects\nWhile SUCRAFT O Tablets are generally well-tolerated, some individuals may experience minor side effects, including:\nConstipation\nDry mouth\nNausea\nAbdominal discomfort\nAllergic reactions such as rash or itching (rare)\n\nIf you experience any severe or persistent side effects, consult your healthcare provider promptly.", "price": 150.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablets function", "work sucraft", "tablet follow", "pain relief", "layer prevents", "damaged mucosa", "itching rare", "generally welltolerated", "bedtime swallow", "typical dosage", "irritation caused", "physical barrier", "comprehensive care", "antiulcer therapies", "acidrelated injury", "protective coating", "fastacting relief", "gastric mucosa", "barrier shields", "protective barrier", "cytoprotective agent", "soothing irritation", "effective relief", "provide fast", "empty stomach", "stomach lining", "accompanies gastric", "excessive acid", "acidity heartburn", "healthcare provider", "acid reflux", "gastric ulcers forms", "erosive gastritis ideal", "acid reflux heartburn", "stomach acid enzymes", "stomach ulcers offering", "healthcare provider promptly", "individuals experiencing conditions", "stomach acids promoting", "gerd peptic ulcers", "physicians guidance strictly", "duodenal disorders directions", "viscous adhesive substance", "ulcer site forming", "burning sensation commonly", "potent local anesthetic", "oxetacaine works synergistically" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2125, "imageuri": "https://productimages.withfloats.com/actual/683450b59b0f1e83d3391585.png", "tileimageuri": "https://productimages.withfloats.com/tile/683450b59b0f1e83d3391585.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-26T11:28:53.131Z", "updatedon": "2026-03-12T10:45:31.126Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sucralfate-oxetacaine/2125", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "GASTROLOGYRANGE", "tags": [ "Sucralfate & Oxetacaine", "Sucralfate & Oxetacaine Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }